+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cancer Gene Therapy"

Gene Therapy Deal-Making Trends, 2012-17 - Product Thumbnail Image

Gene Therapy Deal-Making Trends, 2012-17

  • Report
  • February 2018
  • 62 Pages
  • Global
From
From
From
From
From
Gene Therapy in Oncology - Thematic Research - Product Thumbnail Image

Gene Therapy in Oncology - Thematic Research

  • Report
  • June 2021
  • Global
From
From
From
From
United Arab Emirates Gene Therapy Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2028 - Product Thumbnail Image

United Arab Emirates Gene Therapy Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2028

  • Report
  • July 2022
  • 40 Pages
  • United Arab Emirates United Arab Emirates
From
From
Loading Indicator

The Cancer Gene Therapy market is a subset of the larger Genomics market, which focuses on the study of genes and their functions. Cancer Gene Therapy is a form of treatment that uses genetic material to treat or prevent cancer. It involves introducing genetic material into cells to modify their behavior, such as to stop the growth of cancer cells or to make them more sensitive to chemotherapy. This type of therapy has the potential to be more effective and less toxic than traditional treatments. Cancer Gene Therapy is still in its early stages of development, but it has the potential to revolutionize cancer treatment. It is being studied in clinical trials and is expected to become more widely available in the future. Companies in the Cancer Gene Therapy market include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, and Allergan. Show Less Read more